ABSTRACT
INTRODUCTION
Inflammation is one of the organism´s principal defensive reactions. It is a reaction of the vascular connective tissue to an aggressive agent characterized by the movement of liquid and cells from the blood stream to the interstices, while an infection is defined as the invasion and multiplication of microorganisms. Although its causes such as traumatism, microorganisms, chemical agents and heat vary considerably, the mechanisms for the appearance of inflammations are similar (Brasileiro filho, 2000; Mitchell and Cotran, 2003) . The conventional imaging techniques such as radiology, computerized tomography (CT) and nuclear magnetic resonance (NMR) are not capable of differentiating between inflammatory and infectious processes. In addition, these techniques are based on important anatomic alterations and the possibility of a precocious diagnosis is limited (Becker, 1995) .
Contrary to conventional imaging techniques, imaging scintilography is based on physiological and biochemical alterations resulting from inflammatory and infectious processes. The radiolabeled leucocytes can be considered gold standard for the identification of inflammatory foci in the intestine and bone tissue Martin-Comin et al., 2002) However, the need to handle potentially contaminated blood can lead to the transmission of virus such as HIV and hepatitis B and C. In addition, the preparation of this radiopharmaceutical is laborious and requires specialized equipment, taking approximately three hours. The labeled leucocytes are not able to distinguish aseptic from septic inflammations. The development of new radiopharmaceuticals that do not require the manipulation of blood, able of to differentiate between inflammatory and infectious processes with high sensibility and specificity has been the object of recent research. Therefore, other preparations such as 99m 67 Gacitrate and 99m Tc or 111 In-labeled human polyclonal immunoglobulin are currently being tested (Weiner, 1990; Buscombe et al., 1991; McAfee et al., 1991 Becker, 1995 . However, none of the preparations is capable of distinguishing between infections and inflammatory lesions in a clinically useful manner. A new proposal is based on the use of radiolabeled antibiotics. Currently, the use of these antibiotics is restricted to some research centers in Europe. Recently, a new radiopharmaceutical, Tcciprofloxacin (Infecton), has been developed. Infecton is a wide spectrum fluoroquinolone having a biological half-life of 3.5 to 4.5 horas, 70% of the injected dose being eliminated within 24 hours. The microbiological activity is mediated by inactivation of bacterial DNA gyrase (Vinjamuri et al., 1996; Britton et al., 1997; Hall et al., 1998 Tc-CFT) . CFT has a wide spectrum of activity to the betalactamases, binds to the bacterial wall, inhibits the synthesis of peptidoglycan and therefore inhibits the synthesis of bacterial wall, which drives to bacterial death. This antibiotic is sensitive to light, soluble in water and stable at high temperatures. After administration, the excretion occurs by glomerular filtration and tubular secretion. It has a half-life of 1.7 hours, being almost totally eliminated (100%) within 24 hours (Tavares, 2002) . The objective of the present work was the development of a biologically active 99m Tc-ceftizoxime kit capable of identifying infectious foci in an experimental model of infection in rats.
MATERIAL AND METHODS

Preparation of the kit
The kit was produced using a commercial preparation of Ceftizoxime (Cefizox® 1000 IVSmith Kline and French, S.A.) and a solution of sodium dithionite (Na 2 S 2 O 4 -6.0 mg/mL). The solution was filtered through a cellulose ester filter (0.22 µm). Aliquots of 1.0 mL were transferred to glass vials, frozen in liquid nitrogen and lyophilized for 18 hours. After that, some vials were sealed under nitrogen and others under vacuum.
Labeling with 99m
Tc
The kit was reconstituted with 1.0 mL of sodium 
Radiochemical purity The 99m
Tc-ceftizoxime was checked for radiochemical purity by ITLC (instantaneous thin layer chromatography) with silica gel (SG). The Tc-CFT was evaluated by determination of the radiochemical purity after each of these periods (n = 6).
Stability of the kit for labeling
Tc-99m ceftizoxime The stability of the preparation kit was determined at 1, 7, 14, 30 and 60 days after storage: a) freezer at -70 0 C, with and without nitrogen atmosphere; b) freezer at -25 0 C, with and without nitrogen atmosphere (n = 6).
In vitro tests for antimicrobial activity
The antimicrobial activity of the antibiotic was determined by the disk diffusion method in agar plates impregnated with Staphylococcus aureus -ATCC 6538-P (Gram-positive) and Escherichia coli -ATCC 8739 (Gram-negative). Three disks were used with each Petri dish: Disk 1 -25 µg/10µL of 
Experimental Infection Model
Wistar rats, 200-250 g, were anesthetized by intraperitoneal administration of a mixture of Rompun® (12.5 mg/Kg) and Dopalen® (1.25 mg/Kg), and the infectious process was induced by direct injection of Escherichia coli (25 µL) containing approximately 10 8 colony forming units (CFU/mL) into the left thigh muscle (target) of the animals (n = 7). A sterile saline solution (25 µL) was injected into the right thigh (no target) to serve as a control. Tc-CFT was evaluated in Wistar rats (body mass: 200-250 g). Aliquots of each preparation (37 MBq) were injected into the tail vein. One hour after injection, the animals were anesthetized by intra-peritoneal administration of Rompun® (12.5mg/Kg) and Dopalen® (1.25 mg/Kg), and images were obtained on a gamma camera, Vertex Plus.
b) Foci of inflammation/infection
The animals were anesthetized with Rompum®/Ketamin® (1.0 g and 0.25 g/kg) 24 hours after the induction of the infectious focus, and 0.1 mL of 99m Tc-ceftizoxima (37 MBq) was injected into the tail veins of the animals. The planar static images of the anterior position were acquired one, two and six hours after injection using the gamma camera. The regions of interest (ROIs) were drawn around infectious focus left thigh and a comparable zone in the contralateral normal right thigh (control). The target-to-no target ratio was calculated using the following equation:
Counts left thigh target-to/no target = _________________________________ Counts right thigh (control)
Statistical analyses
The results were analyzed by the Student t test for independent samples. The differences were considered statistically significant for values of p = 0.05.
RESULTS
The results for the radiochemical purity of the 99m Tc-CFT, with and without a nitrogen atmosphere, stored in a freezer at -70 ºC and -25 o C for zero, one, two and six hours after labeling, are shown in Table 1 . The data did not show a statistically significant difference for the times investigated. Values expressed as the mean ± sd, n = 6 (p ≥ 0.05).
The kit for labeling of ceftizoxime with 99m
Technetium is stable for at least two months after preparation ( Tc-CFT, unlabeled CFT and CFT + reagents, respectively (Figs. 1 and 2 ).
The biodistribution typical of 99m TcO 4 -with radioactivity uptake by thyroid, stomach and bladder can be seen in Fig. 3a . The 99m Tc-CFT biodistribution showed a high uptake by the kidney, indicating a renal excretion (Fig. 3b) , while the 99m TcO 2 was uptake by the liver and spleen (Fig. 3c) . Values expressed as the mean ± sd, n = 6 (p ≥ 0.05). Ratios of 1.97 ± 0.31, 2.10 ± 0.42 and 2.01 ± 0.42 for the cpm of the left thigh to the cpm of the right thigh were observed for the one, two and six-hour periods, respectively (Table 3 ). These ratios show that there was a significant uptake of Tcceftizoxime by the infectious site in the left thigh. The data suggest that Tc-99m Ceftizoxime remained at the infectious focus during the whole experiment, there being no statistically significant difference in the ratios during the period studied. As can be seen in Figs. 4A, B and C, there was a greater degree of 99m Tc-CFT uptake by the infectious site in the left thigh (arrow) than in the right thigh (control) at one, two and six hours after administration. The images show the uptake of 99m Tc-CFT until six hours after injection, suggesting a specific uptake by the infectious site. Values expressed as the mean ± sd, n=7 (p ≥ 0.05).
DISCUSSION
Although the radiolabeled leucocytes are considered to be a gold standard, this diagnostic agent does not differentiate between inflammation and infection (Sampson, 1996) . Recent studies have demonstrated the possibility of utilizing radiolabeled antibiotics for differencial diagnostic of inflammatory and infectious processes (Sonmezoglu et al., 2001; Yapar et al., 2001) .
The antibiotic that is most widely utilized is a fluorquinolone called Infecton. However, the results obtained have been contradictory with low reproducibility. This fact has generated a certain resistance on the part of the scientific community in accepting it as a reliable diagnostic agent. It may be because some workers have related a non-specific uptake of 99m Tc-Infecton by inflammatory foci that have been proven to be aseptic (Larikka et al., 2002a; Larikka et al., 2002b since ciprofloxacine has a low molecular weight (MW = 331.3), low degree of interaction with plasmatic protein (20-40%) and a biological half-life of 4.5 hours, it would interact with a variety of factors before interacting with bacteria. In this way, the researchers justified the non-specific uptake observed in images after one and four hours. On the other hand, ceftizoxime (CFT) has a halflife of 1.7 hours, being almost totally eliminated within 24 hours after administration. As opposed to Infecton, ceftizoxime is more rapidly depurated from the organism, thus diminishing the circulating pool and favoring the specific capture by the infectious site over the nonspecific. Therefore, considering the criteria for obtaining an ideal radiopharmaceutical, ceftizoxime fits the criteria better. The purpose of the present work was the production of a kit with ceftizoxime in condition to be labeled with 99m Technetium. The preparation of the CFT kit utilized a mixture of solutions containing the antibiotic ceftizoxime (2.5 mg/mL) and the reducing agent sodium dithionite (6.0 mg/mL) that was lyophilized for a period of 18 hours. Part of the material produced was stored under nitrogen atmosphere while the rest were maintained under vacuum. The yield labeling of CFT with 99m Technetium using a kit formulation furnished results equal or superior to 90%. Barreto et al. (2000) obtained similar results varying from 90.5 to 95.8% using a solution of ceftizoxime prepared at the moment of labeling. The results obtained in this work demonstrated that the labeled product was stable for a period of six hours, regardless of the storage conditions. In addition, the time and temperature of storage did not interfere with the labeling yield, showing that the kit preparation was stable for two months ( Table 2) . One of the essential characteristics in the preparation of the CFT kit is the preservation of the biological activity. In vitro tests with Staphylococcus aureus and Escherichia coli cultures presented inhibition halos of 27.16±0.23 Tc-CFT. This observation showed that the labeled antibiotic was capable of recognizing both gram negative and gram positive bacteria, suggesting that the antibiotiic preserved its broad spectrum of activity even after labeling. The inhibition halos using non-labelled ceftizoxime were 30.4±0.33 and 29.43±0.26 mm for S. aureus and E.coli, respectively. Thus, there was a 10% reduction in the biological activity of 99m Technetium-labeled ceftizoxime relative to that of the non-labeled ceftizoxime. Barreto et al. (2000) observed a reduction in the biological activity on the order of 17% utilizing an E.coli culture and 99m Tc-CFT. Considering only the data obtained for E.coli in the present study, it can be seen that the attenuation of the biological activity of 99m Tc-CFT was 7.7%, suggesting that the formulation of a kit may be contributing for an improved preservation of the biological activity. When the images obtained with Tc-CFT by the kidneys one hour after administration. This observation suggests that there is a rapid depuration of the labeled product, a result that is in accord with its characteristics described in the literature. At the same time, these data indicate that the Tc-CFT by the infectious site in the left thigh than in the control thigh. A constant ratio of target/no target during the experiment was observed, indicating that the labeled antibiotic remained at the site of infection. The image obtained six hours after administration of 99m Tc-CFT also exhibited the presence of the labeled drug at the site of infection, suggesting a specific bind between the 99m Tc-CFT and the infectious agent. The hypothesis that the labeled product would be encountered at this site simply because of an increase in blood flow and an increase in the vascular permeability provoked by the inflammation resulting from the infectious process must be discarded since the uptake of 99m Tc-CFT was present at the target site until six hours after administration. Benitez et al. (2002) showed that the uptake of Technetium for the investigation of infectious processes. However, additional studies related to the storage conditions and the stability over periods greater than two months should be performed before the commercial production of a CFT Kit will be viable. acquisition of the images of the animals with the gamma camera.
RESUMO
O objetivo deste trabalho foi preparar um kit de Ceftizoxima ( 99m Tc-CFT), com estabilidade e atividade biológica preservadas, capaz de identificar um foco séptico (E.coli) em um modelo experimental de infecção em ratos. A preparação do kit de CFT baseou-se em uma mistura de soluções contendo o antibiótico ceftizoxima (2,5mg/mL) e o agente redutor ditionito de sódio (6,0mg/mL) que foram submetidos a um processo de liofilização. Após a liofilização, o kit foi reconstituído with 1,0 mL de solução de pertecnetato de sódio (Na Tc-CFT nos animais com focos infecciosos mostraram uma relação alvo/não alvo de 1,97±0,31, 2,10±0,42 e 2,01±0,42 para os tempos de 1, 2 e 6 horas, respectivamente. As imagens obtidas mostraram nítida captação do antibiótico marcado ( 99m Tc-CFT) pelo foco infeccioso ao longo do experimento. Os resultados obtidos neste trabalho atestam a viabilidade de produção de um kit da ceftizoxima marcada com 99m tecnécio para investigações de processos infecciosos.
